ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,424.20
0.05%
Dow Jones
39,806.77
-0.49%
Gold vs US Dollar
2,427.87
0.06%
Brent Oil
83.325
-0.25%
Bitcoin
71,071.64
-0.53%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zentalis Pharmaceuticals Inc (ZNTL)

  7. Zentalis Pharmaceuticals Inc (ZNTL) News

Zentalis Pharmaceuticals (ZNTL)

Zentalis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZNTL
DateTimeSourceHeadlineSymbolCompany
14/05/202412:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation SummitNASDAQ:ZNTLZentalis Pharmaceuticals Inc
07/05/202412:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
07/05/202412:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
07/05/202412:00GlobeNewswire Inc.Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational ProgressNASDAQ:ZNTLZentalis Pharmaceuticals Inc
01/05/202422:30GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
02/04/202421:05GlobeNewswire Inc.Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024NASDAQ:ZNTLZentalis Pharmaceuticals Inc
01/04/202422:30GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
01/03/202423:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/02/202422:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ZNTLZentalis Pharmaceuticals Inc
29/02/202422:14Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZNTLZentalis Pharmaceuticals Inc
28/02/202412:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
27/02/202412:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
27/02/202412:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
27/02/202412:00GlobeNewswire Inc.Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational UpdatesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
15/02/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
14/02/202400:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/02/202412:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences ConferenceNASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/02/202401:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/02/202401:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
13/02/202401:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/02/202400:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/02/202400:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/02/202400:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
06/02/202400:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/02/202402:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/02/202402:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/02/202402:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/02/202402:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
03/02/202402:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
01/02/202422:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZNTL

Your Recent History

LSE
0A8U
Synlogic
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved